A nonsignificant trend for higher CD3, CD8, CD4, and FOXP3 positive cells, as evaluated by immunohistochemistry, was observed in CR vs NR pre-treatment samples and was also present after treatment.
← all excerpts
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.
1
—
—